Lakdawalla, Darius N. http://orcid.org/0000-0001-5934-8042
Doctor, Jason N. http://orcid.org/0000-0003-3661-8745
Funding for this research was provided by:
University of Southern California
Article History
Received: 15 August 2023
Accepted: 5 December 2023
First Online: 27 February 2024
Declarations
:
: In the past 3 years, Dr. Lakdawalla has received speaker fees, travel assistance, or consulting income from the following sources: Amgen, Genentech, Gilead, GRAIL, Mylan, Novartis, Otsuka, Perrigo, Pfizer, and Sorrento Therapeutics. Dr. Lakdawalla owns equity in Precision Medicine Group, for which he previously served as a consultant. Dr. Lakdawalla is also Co-Founder and Chief Scientific Officer of EntityRisk, Inc., which develops software and analytic tools for use by healthcare firms. Jason Doctor reports no competing interests.